MedImmune - M&A Summary, Ownership, and Business Overview

Medical ProductsCompany

MedImmune M&A Summary

MedImmune has acquired 6 companies of its own. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.

MedImmune’s largest acquisition to date was in 2013, when it acquired Amplimmune for $500M. MedImmune has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).

MedImmune Ownership

Who owns MedImmune?

MedImmune is owned by AstraZeneca. It was acquired on June 1, 2007.

MedImmune Business Overview

Where is MedImmune headquartered?

MedImmune is headquartered in Gaithersburg, Maryland.

How many employees does MedImmune have?

MedImmune has 2,000 employees.

What sector is MedImmune in?

MedImmune is a medical products company.

When was MedImmune founded?

MedImmune was founded in 1988.

M&A Summary

  • M&A Total Activity7
    • M&A Buy Activity6
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 2

MedImmune LLC

MedImmune Way ,
Gaithersburg, Maryland 20878
United States,
(301) 398-0000
www.medimmune.com

MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With approximately 2,000 employees worldwide, MedImmune is headquartered in Maryland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 6 - - - - - 6
vol $1.2B $1.2B
Sell (0.2/yr) # - 1 - - - - 1
  7

Most Recent M&A

Company Date Value Type
ADC Therapeutics SA 2020-05-11 - IPO
Epalinges, Switzerland · www.adctherapeutics.com
Spirogen Ltd. 2013-10-15 240M USD Add-on Acquisition
London, United Kingdom · www.spirogen.com
ADC Therapeutics SA 2013-10-15 - Growth Capital
Epalinges, Switzerland · www.adctherapeutics.com
Amplimmune, Inc. 2013-08-26 500M USD Add-on Acquisition
Gaithersburg, Maryland · www.amplimmune.com
AlphaCore Pharma LLC 2013-04-03 - Add-on Acquisition
Ann Arbor, Michigan · www.alphacorepharma.com
Cellective Therapeutics, Inc. 2005-09-14 - Add-on Acquisition
Gaithersburg, Maryland · www.medimmune.com
U.S. Bioscience, Inc. 1999-09-23 492M USD Add-on Acquisition
West Conshohocken, Pennsylvania
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 6 (100%) 1.2B (100%) 1 (100%) -
Total 6 $1.2B 1 -

By Geo

State/Country Buy Value Sell Value
United States 4 992M - -
  Maryland 2 500M - -
  Pennsylvania 1 492M - -
  Michigan 1 - - -
Switzerland 1 - 1 -
United Kingdom 1 240M - -
Domestic 4 (67%) 992M (81%) - -
Cross-border 2 (33%) 240M (19%) 1 (100%) -
Total 6 $1.2B 1 -

Deal Values

buy # Total
$100M to $1B 3 $1.2B
TOTAL $1.2B
Largest Amplimmune, Inc.
$500M (2013-08-26)

M&A Connections

Deals
Acquired from
Investor(s)
33%
2 (33%)

 Subscribe to unlock this and 201,649
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.